Aslan A. Aygun
Cerrahpasa, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Comparative intra-articular retention of [177Lu]Lu-MAA and 90Y resin in a rat knee model.
Journal: Nuclear medicine and biology
Published: February 14, 2026
Influence of Venous Access Site and Right Atrial Anatomical Variants on the Detection of Patent Foramen Ovale During Agitated Saline Contrast Transesophageal Echocardiography.
Journal: Echocardiography (Mount Kisco, N.Y.)
Published: November 09, 2025
Evaluation of VOR function with vHIT in unilateral pediatric cochlear implant users.
Journal: International journal of pediatric otorhinolaryngology
Published: June 11, 2024
US-guided percutaneous ablation of thyroid nodules with 177LU-MAA (LUTMA) - Feasibility study.
Journal: Revista espanola de medicina nuclear e imagen molecular
Published: April 16, 2024
Small Molecule, Multimodal, [18F]-PET and Fluorescence Imaging Agent Targeting Prostate-Specific Membrane Antigen: First-in-Human Study.
Journal: Clinical genitourinary cancer
Published: January 27, 2021
Comparison of Ga-68 PSMA positron emission tomography/computerized tomography with Tc-99m MDP bone scan in prostate cancer patients
Journal: Turkish journal of medical sciences
Published: February 15, 2019
177Lu-Labeled Macroaggregated Albumin Imaging and Treatment Effect in Patient with Cystic Thyroid Nodule.
Journal: Journal of nuclear medicine technology
Published: January 18, 2019
Lu-177-PSMA-617 Prostate-Specific Membrane Antigen Inhibitor Therapy in Patients with Castration-Resistant Prostate Cancer: Stability, Bio-distribution and Dosimetry.
Journal: Molecular imaging and radionuclide therapy
Published: June 15, 2017
The role of PSMA PET/CT imaging in restaging of prostate cancer patients with low prostate-specific antigen levels.
Journal: Nuclear medicine communications
Published: November 29, 2016
Pre-therapeutic dosimetry of normal organs and tissues of (177)Lu-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: April 27, 2015
Evaluation of PSMA PET/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging.
Journal: Nuclear medicine communications
Published: March 05, 2015
Evaluation and comparison of Ga-68 DOTA-TATE and Ga-68 DOTA-NOC PET/CT imaging in well-differentiated thyroid cancer.
Journal: Nuclear medicine communications
Published: August 14, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026